Logo image of TAOP

TAOPING INC (TAOP) Stock Fundamental Analysis

USA - NASDAQ:TAOP - VGG8675V1351 - Common Stock

2.96 USD
-0.19 (-6.03%)
Last: 10/10/2025, 2:04:02 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to TAOP. TAOP was compared to 86 industry peers in the IT Services industry. TAOP has a bad profitability rating. Also its financial health evaluation is rather negative. TAOP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year TAOP has reported negative net income.
In the past year TAOP has reported a negative cash flow from operations.
TAOP had negative earnings in each of the past 5 years.
TAOP had a negative operating cash flow in each of the past 5 years.
TAOP Yearly Net Income VS EBIT VS OCF VS FCFTAOP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

The Return On Assets of TAOP (-5.18%) is worse than 69.77% of its industry peers.
Looking at the Return On Equity, with a value of -11.46%, TAOP is doing worse than 63.95% of the companies in the same industry.
Industry RankSector Rank
ROA -5.18%
ROE -11.46%
ROIC N/A
ROA(3y)-10.54%
ROA(5y)-22.01%
ROE(3y)-30.3%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TAOP Yearly ROA, ROE, ROICTAOP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400

1.3 Margins

The Gross Margin of TAOP (21.19%) is worse than 82.56% of its industry peers.
TAOP's Gross Margin has declined in the last couple of years.
TAOP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.03%
GM growth 5Y-15.03%
TAOP Yearly Profit, Operating, Gross MarginsTAOP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

3

2. Health

2.1 Basic Checks

TAOP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TAOP has been increased compared to 1 year ago.
Compared to 5 years ago, TAOP has more shares outstanding
TAOP has a better debt/assets ratio than last year.
TAOP Yearly Shares OutstandingTAOP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100K 200K 300K 400K
TAOP Yearly Total Debt VS Total AssetsTAOP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

TAOP has an Altman-Z score of -6.41. This is a bad value and indicates that TAOP is not financially healthy and even has some risk of bankruptcy.
TAOP has a Altman-Z score of -6.41. This is amonst the worse of the industry: TAOP underperforms 89.53% of its industry peers.
A Debt/Equity ratio of 0.50 indicates that TAOP is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.50, TAOP perfoms like the industry average, outperforming 45.35% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Altman-Z -6.41
ROIC/WACCN/A
WACC7.18%
TAOP Yearly LT Debt VS Equity VS FCFTAOP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

A Current Ratio of 2.19 indicates that TAOP has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.19, TAOP is doing good in the industry, outperforming 65.12% of the companies in the same industry.
TAOP has a Quick Ratio of 1.72. This is a normal value and indicates that TAOP is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.72, TAOP is in line with its industry, outperforming 54.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.19
Quick Ratio 1.72
TAOP Yearly Current Assets VS Current LiabilitesTAOP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

3

3. Growth

3.1 Past

TAOP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.84%, which is quite impressive.
The Revenue has decreased by -5.08% in the past year.
The Revenue has been growing by 21.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)72.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-157.16%
Revenue 1Y (TTM)-5.08%
Revenue growth 3Y23.65%
Revenue growth 5Y21.59%
Sales Q2Q%-24.28%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
TAOP Yearly Revenue VS EstimatesTAOP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

TAOP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TAOP Price Earnings VS Forward Price EarningsTAOP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as TAOP.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.73
TAOP Per share dataTAOP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

TAOP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TAOPING INC

NASDAQ:TAOP (10/10/2025, 2:04:02 PM)

2.96

-0.19 (-6.03%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)09-07 2022-09-07/bmo
Earnings (Next)N/A N/A
Inst Owners0.67%
Inst Owner Change-10.81%
Ins Owners22.77%
Ins Owner ChangeN/A
Market Cap4.03M
Analysts82.86
Price TargetN/A
Short Float %2.66%
Short Ratio0.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B 0.25
P/tB 0.25
EV/EBITDA 16.73
EPS(TTM)-4.85
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.53
FCFYN/A
OCF(TTM)-1.75
OCFYN/A
SpS26.97
BVpS11.67
TBVpS11.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.18%
ROE -11.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.19%
FCFM N/A
ROA(3y)-10.54%
ROA(5y)-22.01%
ROE(3y)-30.3%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.03%
GM growth 5Y-15.03%
F-Score1
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Debt/EBITDA 15.51
Cap/Depr 49.76%
Cap/Sales 2.87%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.19
Quick Ratio 1.72
Altman-Z -6.41
F-Score1
WACC7.18%
ROIC/WACCN/A
Cap/Depr(3y)38.3%
Cap/Depr(5y)93.6%
Cap/Sales(3y)4.47%
Cap/Sales(5y)17.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-157.16%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.08%
Revenue growth 3Y23.65%
Revenue growth 5Y21.59%
Sales Q2Q%-24.28%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-713.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2.52%
OCF growth 3YN/A
OCF growth 5YN/A